Cargando…
Comparative of the effectiveness and safety of biological agents, small molecule drugs, and microbiome therapies in ulcerative colitis: Systematic review and network meta-analysis
BACKGROUND: Biological agents are commonly used for the first-line treatment of ulcerative colitis (UC). However, small-molecule drugs and microbiome therapies are now being used as new treatments for ulcerative colitis. We aimed to compare the relative efficacy and safety of biologics, small-molecu...
Autores principales: | Gao, Jie, Nie, Rui, Chen, Yalan, Yang, Wei, Ren, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615430/ https://www.ncbi.nlm.nih.gov/pubmed/37904440 http://dx.doi.org/10.1097/MD.0000000000035689 |
Ejemplares similares
-
Beverage consumption and risk of ulcerative colitis: Systematic review and meta-analysis of epidemiological studies
por: Nie, Jia-Yan, et al.
Publicado: (2017) -
Optimizing individualized management of patients with ulcerative colitis: Identification of risk factors predicting ulcerative colitis-associated neoplasia
por: Jiang, Wenyu, et al.
Publicado: (2023) -
The ulcerative colitis endoscopic index of severity score is superior to reflecting long-term prognosis in ulcerative colitis patients treated with vedolizumab
por: Yan, Jing, et al.
Publicado: (2023) -
Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: A meta-analysis
por: Jia, Xuemei, et al.
Publicado: (2020) -
Efficacy and safety evaluation of acupoint embedding for patients with ulcerative colitis: A protocol of systematic review and meta-analysis
por: Lu, Jinhua, et al.
Publicado: (2020)